The laboratory of Dr. Shan Lu at the University of Massachusetts Medical School (UMMS) has provided CytoDyn, Inc. (Pink Sheets:CYDY) with updated DNA-based H1 and H3 serotype influenza vaccines for the 2007-2008 flu season. Updating of the DNA-based flu vaccines was completed in less than 1.5 months following a recommendation by the World Health Organization. It takes much longer to make an updated flu vaccine using the wild or natural virus, a technique that was developed in the nineteenth century and is still being used by the major vaccine providers.
CytoDyn will use both types of vaccines in clinical trials to evaluate the prime-boost method of vaccination invented...
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry